The thioredoxin system, composed of thioredoxin and thioredoxin reductase, emerges as one of the most important thiol-based systems involved in the maintenance of the cellular redox balance. Thioredoxin-like-1 (TXL-1) is a highly conserved protein comprising an N-terminal thioredoxin domain and a C-terminal domain of unknown function. Here we show that TXL-1 is a substrate for the cytosolic selenoprotein thioredoxin reductase. In situ hybridization experiments demonstrates high expression of Txl-1 mRNA in various areas of central nervous system and also in some reproductive organs. Glucose deprivation, but not hydrogen peroxide treatment, reduced the levels of endogenous TXL-1 protein in HEK-293 cell line. Conversely, overexpression of TXL-1 protects against glucose deprivation-induced cytotoxicity. Taken together, the finding that Txl-1 mRNA is highly expressed in tissues which use glucose as a primary energy source and the modulation of TXL-1 levels upon glucose deprivation indicate that TXL-1 might be involved in the cellular response to sugar starvation stress. 
INTRODUCTION
The thioredoxin family encompasses a group of redox proteins that function as general protein disulphide reductases [8] participating in many physiological and pathophysiological processes [1, 5] . The redox activity of thioredoxins (Trx) is directly linked to their highly conserved active site (Cys-Gly-Pro-Cys) where the cysteine residues can undergo a reversible oxidation from a dithiol to a disulphide form.
Oxidized inactive forms are reduced by the selenoprotein thioredoxin reductase (TrxR), which uses the reducing power of NADPH [9] . Thioredoxins share a common globular structure consisting of a central core of β-sheets surrounded by α-helixes with the active site situated in a protrusion of the protein surface [12] .
Different forms of thioredoxins have been reported in all organisms from prokaryotes to humans. In eukaryotic organisms thioredoxins are located in different subcellular compartments and are found either ubiquitously expressed or specifically localized in particular tissues [2, 8, 11, 17, 20, 21, 23] . Some of the previously described thioredoxins comprise additional domains with known or unknown counterparts in the databases [2, 17, 21, 22, 26, 27] .
Thioredoxin-like 1 (TXL-1), also known as TRP32 [17, 21] is a two-domain protein of 32 kDa composed of a N-terminal thioredoxin domain followed by a C-terminal domain of unknown function with no homology with any other protein in the databases. TXL-1 mRNA is ubiquitously localized in all human tissues examined so far, although it is present at highest levels in tissues with an elevated metabolic rate [17, 21] . The crystal structure of the TXL-1 N-terminal domain has been solved [14] and shows a monomeric structure, in contrast to the ubiquitous cytosolic TRX-1 which is dimeric in all crystal structures reported [37] .
We report here novel features of human TXL-1 concerning its ability to serve as substrate for thioredoxin reductase, new insights into its tissue localization and, more importantly, that TXL-1 is involved in the cellular response to glucose deprivation.
MATERIAL AND METHODS

Materials:
All media and supplements used for cell culture including glucose-free DMEM were purchased from Life Technologies. Bovine thioredoxin reductase was from IMCO (Sweden). pET-15b vector was obtained from Novagen and pGEX-4T-1 vector was from Amersham Biosciences. pCDNA-myc empty vector was a gift from Dr. Eckardt Treuter. Anti-myc monoclonal antibody was purchased from Invitrogen. H 2 O 2 , Trypan Blue and MTT reagents were obtained from Sigma-Aldrich.
Human TXL-1 protein expression and purification: The ORF encoding human TXL-1 was cloned into the BamHI-EcoRI sites of the pGEX-4T-1 expression vector and used to transform E. coli HMS174(DE3). Induction and purification of the recombinant protein was achieved as previously reported [21] . Thrombin (5 units/mg of fusion protein) was used to remove the glutathione S-transferase domain by incubation overnight at 4°C. The resulting protein preparation was then subjected to ion exchange chromatography using a Resource Q column (Amersham Biosciences), and human TXL-1 was eluted as a single peak using a gradient of NaCl. Protein concentration was determined with the Bio-Rad protein assay kit (BioRad) using BSA as a standard.
Enzymatic Activity Assays: Enzymatic activity of recombinant human TXL-1 was performed using two different assays. In the DTT assay, DTT is used as reducing agent and the assay was carried out as previously described [38] . In the thioredoxin reductase assay, recombinant TXL-1 activity was determined by its capability to reduce insulin disulfide bonds using NADPH as electron donor in the presence of calf thymus thioredoxin reductase-1. The activity assay was performed essentially as described elsewhere [33] but monitoring insulin precipitation at 600nm. In both cases, human TRX-1 was used as control.
Antibody production: Purified His-hTXL-1 [21] was used to immunize rabbits (Zeneca Research Biochemicals). After six immunizations, serum from rabbits was purified by ammonium sulfate precipitation. Affinity-purified antibodies were prepared as described [24] using the TXL-1 fragment from the GST-TXL-1 recombinant protein. The specificity of the antibodies was tested by western blot.
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Immunodetection was performed with horseradish peroxidase-conjugated donkey anti-rabbit IgG diluted 1/5,000 following the ECL protocol (Amersham Biosciences).
Additionally, affinity purified polyclonal rabbit anti-TXL-1 and the respective blocking peptide were purchased from Abgent (San Diego, USA) for immunocytochemistry.
In situ hybridization: Adult (NMRI, weighting 20-25 g) and embryonic (embryonic days E9 -E18; E1 = the day of copulation plug) mice were used. Adult animals were killed with carbon dioxide, the tissues and embryos were rapidly excised, and frozen on dry ice. The frozen tissues were sectioned with Microm HM-500 cryostat at 14 µm and mounted on Polylysine glass slides (Menzel, Braunschweig, Germany). The sections were stored at -20ºC until use. Three oligonucleotide probes directed against mouse and rat Txl-1 mRNA (mouse nucleotides 189-222, 263-294 and 361-394, GeneBank accession number NM_016792) were used for in situ hybridization.
The sequences exhibited less than 60% homology with other known genes in the GeneBank database. Several probes against non-related mRNAs with known expression patterns and with similar length and GC-content were used as controls.
Addition of 100-fold excess of non-labeled probes quenched all signal. The in situ hybridization was carried out as described in detail previously [28] . Cell culture and transient transfections: HEK-293 cells were cultured at 37ºC in an atmosphere of 5% CO 2 in DMEM medium supplemented with 10% fetal bovine serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Transfection experiments were carried out as described elsewhere [13] . MTT cell viability assay: Cell viability was assessed by MTT assay [25] that detects the cellular ability to transform MTT tetrazolium salt into formazan. MTT (0.3 mg/ml in DMEM without phenol red) was added to the cells. After 1 h incubation at 37ºC, the medium was removed and the formazan crystals were dissolved in the same volume of isopropanol. Aliquots were transferred to 96-well plates and the absorbance was measured at 540nm. Results were expressed as a percentage of viable cells.
Statistical analysis: Analyses of differences were carried out by ANOVA followed by the Student-Newman-Keuls post-hoc test. A value of p<0.05 was considered statistically significant.
RESULTS
Txl-1 is a two-domain protein conserved from fission yeast to humans
A protein-protein BLASTp search was performed to identify human TXL-1 orthologues in the public databases (http://www.ncbi.nlm.nih.gov/BLAST/), which resulted in several entries from the fission yeast to mammals. All these sequences were run on a W-Clustal alignment using the MegAlign program included in the DNAstar software package (Supplemental Data Fig. 1 ). Txl-1 protein is well conserved from lower eukaryotes to humans and the high identity is not only confined to the thioredoxin domain, but being comparable all along the protein sequence. All the Txl-1 proteins analyzed are about the same length (290 residues) and contain many of the amino acid residues identified as essential for catalysis, maintenance of three-dimensional structure or protein-protein interactions in previously characterized thioredoxins [3] .
As mentioned above, Txl-1 is a two-domain protein with an N-terminal thioredoxin domain and a C-terminal domain with unknown function [17, 21] . Nonetheless, the 
Human TXL-1 has reducing activity coupled to thioredoxin reductase
We have now purified a GST-TXL-1 recombinant protein and assayed the thrombin-cleaved TXL-1 in the DTT assay resulting in detectable enzymatic activity, as previously reported [17] (data not shown). Recombinant thrombin-cleaved TXL-1 protein also displayed thioredoxin reducing activity in the presence of calf thymus thioredoxin reductase and NADPH (Fig. 1) . Remarkably, the kinetics of TRX-1 and TXL-1 are different. First, TRX-1 shows a 4-fold higher thioredoxin activity than TXL-1 at the same concentration. Second, TXL-1 activity is delayed in time when 8 compared to that of TRX-1. TXL-1 starts to show the enzymatic activity after 45 min of initiating the assay, when TRX-1 has already reached its maximal activity. This long latency phase explains the failure to detect thioredoxin reductase-dependent activity of TXL-1 in our previous report [21] .
Txl-1 mRNA tissue distribution
With in situ hybridization in mice, high level of Txl-1 mRNA could be seen in several areas in nervous system. Especially olfactory bulb, hippocampus, habenular nucleus, several hypothalamic ( Fig. 2A ) and brain stem nuclei and cerebellar cortex (Fig. 2B) showed high expression. In peripheral nervous system moderate expression was seen in the neurons of trigeminal and superior cervical ganglion (Fig.   2C ). In reproductive organs high expression was seen in the granulosa cells of different size follicles in ovary, while interstitial tissue and corpora lutea showed low expression (Fig. 2D) . In testis moderate signal was observed in most seminiferous tubules (Fig. 2E) . In epididymis strong signal was present in the epithelium of the tubules (Fig. 2F ). In prostate low signal was seen in the epithelium (Fig. 2G ) and in seminal vesicle low expression was seen in the muscle layer. In immune system moderate levels of Txl-1 mRNA were observed in thymus (Fig. 2H ), spleen and lymph nodes. In kidney moderate expression was present in the cortex and outer medulla while inner medulla and pelvis were devoid of signal (Fig. 2I) . In urinary bladder low signal was present in the epithelium whereas muscle layer was devoid of signal. In salivary gland and liver (Fig. 2J ) moderate homogenous signal was present. Pituitary gland and adrenal gland (Fig. 2K) showed low signal while thyroid gland was devoid of signal. In heart (Fig. 2L ) and striated muscle (Fig. 2M) expression of Txl-1 mRNA was low. In skin low expression could be detected (Fig.   2M ). Strong Txl-1 mRNA expression was seen in the embryonic side of the E9 placenta, while maternal side showed low expression. In E9 fetus clear signal was seen in the neuroepithelium of developing neural tube (Fig. 2N) . Most organs which express Txl-1 mRNA in adults showed expression already during fetal development (data not shown).
Immunocytochemical localization of TXL-1 in brain
As the central nervous system is one of the organs showing high levels of Txl-1 mRNA, we further analyzed the expression pattern of Txl-1 protein in mouse brain tissue by immunocytochemistry.
Txl-1 immunoreactivity could be seen in several brain areas. Strong staining was seen in e.g. cerebral and cerebellar cortex (Fig. 3A) and hypothalamus (Fig. 3B) . In cerebellar Purkinje neurons strong nuclear staining was evident. Moderate to low labeling was seen in the cytoplasm (Fig. 3A) . Large number of granular neurons showed strong nuclear labeling and weak cytoplasmic staining. Few granular neurons exhibited moderate cytoplasmic staining with weak or non-labeled nucleus (Fig. 3A) . In hypothalamic arcuate nucleus both nuclear and cytoplasmic staining was seen in most of the labeled cells while in some on cytoplasmic staining was evident (Fig. 3B) . No staining was seen in the presaturation control (Fig. 3C ).
In addition, we clearly observed both nuclear and cytoplasmic localization of a TXL-1-GFP fusion protein (Supplemental Data Fig. 2 ). Although the nuclear staining is weaker than with a transfection control using the pEGFP-N3 empty vector expressing the GFP protein alone, a comparison with cells transfected with pEGFP-N3/SPTRX-2 that express the cytoplasmic-restricted sperm-specific thioredoxin 2
[26] allow us to unequivocally confirm the nuclear labeling of TXL-1-GFP fusion protein.
Glucose deprivation but not hydrogen peroxide affects TXL-1 expression levels in HEK-293 cells
Brain tissue is very sensitive to ischemia (i. e. hypoxia and glucose deprivation). In addition, glucose deprivation induces cell death through a mechanism where metabolic oxidative stress is involved [18, 30, 31] . We wanted to know whether TXL-1 might be involved in this mechanism and therefore we investigated TXL-1 expression in HEK-293 cells after glucose deprivation. First, we confirmed that glucose-deprivation, as reported for other cell lines [18, 32] , induces cell death in HEK-293 cells (Fig. 4, left panel) . Cytotoxicity is evident after 24h of treatment, counting up to 60% of cell death after 48h. With regard to TXL-1 expression upon glucose deprivation, TXL-1 protein levels do not change until 32 h (not shown) and decrease after 36 h when HEK-293 cells are cultured in glucose-free medium (Fig. 4 , right panel). In contrast, glucose deprivation does not affect TRX-1 or actin protein levels up to 48h.
Glucose deprivation-induced cytotoxicity is mediated by the generation of reactive oxygen species such as hydrogen peroxide [30] . Based on our previous results, we reasoned that the downregulation of TXL-1 expression caused by glucose deprivation might be mediated by hydrogen peroxide. Therefore, we checked whether hydrogen peroxide by itself might trigger modifications on TXL-1 protein levels. As shown in Fig. 5 , hydrogen peroxide induces HEK-293 cell death within 2 h, reaching only 50% survival after 6 h, but does not cause any change in the endogenous levels of TXL-1. Extended incubation times caused massive cell death without any change in the levels of TXL-1 (not shown).
TXL-1 overexpression protects against glucose deprivation induced cytotoxicity
Next we wanted to know if TXL-1 overexpression might abolish or delay the cell death induced by glucose deprivation in HEK-293 cells. For this purpose, we made stable cell lines overexpressing TXL-1 to check whether constitutively increased TXL-1 protein levels have a protective effect on glucose deprivation-induced cytotoxicity. As shown in Fig. 6 we managed to isolate two stable clones with different TXL-1 expression levels (TXL-1-6 and TXL-1-16, with high and low expression levels of recombinant TXL-1, respectively) and one stable cell line with the pCDNA-myc empty vector to be used as negative control. Our results indicate that increased levels of TXL-1 can protect against the cytotoxicity induced by 48 to 72 h of glucose deprivation (Fig. 6) . Thus, TXL-1-6 clone that expresses high levels of TXL-1 protein shows a significant delay in cell death and a higher rate of survival (about 50% more living cells than the control) from 48 h to 72 h (Fig. 6) . However, TXL-1-16 clone that expresses low levels of TXL-1 is as sensitive as the control. In contrast, TXL-1 overexpression does not exert any effect against hydrogen peroxide cytotoxicity (not shown).
Discussion
Oxidative stress is involved in the progression of many different diseases and it is characterized by the depletion of the general antioxidant systems leading to an alteration of the cellular redox status. Thus, the balance between ROS production and antioxidants determines the degree of oxidative stress [4] . Thioredoxins have emerged as an essential family of proteins directly related to the antioxidant cellular network [5] . Here we present novel features of one member of the thioredoxin family, thioredoxin-like-1.
Txl-1 is one of the best conserved members of the thioredoxin family. This fact probably implies an important function of this protein in the physiology of eukaryotic organisms. It is also remarkable that the active site of Txl-1 homologues in lower eukaryotes and invertebrates contains a tryptophan residue (WCGPC), as is also the case of most thioredoxins [10] , while in Txl-1 from vertebrates, this tryptophan residue is substituted by a glycine residue (GCGPC). The presence of the bulky imidazole side chain of Trp31 has been proposed to regulate the catalytic activity of thioredoxins [16] . Indeed, we found that the thioredoxin activity kinetics are considerably different between TXL-1 and TRX-1, making it reasonable to speculate that the substitution of Trp31 to Gly31 might explain this difference. Nonetheless, the biological significance of this change requires further analysis.
High expression of Txl-1 mRNA could be seen in tissues which mainly use glucose as an energy source and low expression in tissues which utilize fatty acids as energy supplier. This finding aimed us to further investigate the localization of Txl-1 in brain, which in normal situation relies solely on glucose. Our results show that Txl-1 can be seen either in the nucleus or the cytoplasm of different cells types in the brain (Fig.   3 ). In addition, a TXL-1-GFP fusion protein also displays both nuclear and cytoplasmic localization (Supplementary Data Fig. 2) , thus confirming the TXL-1 subcellular localization pattern observed with immunocytochemistry. However, there is no nuclear targeting signal in the TXL-1 sequence. In close parallelism, TRX-1 can also translocate into the nucleus under certain conditions [7] without such targeting signal in its sequence. The roles of TRX-1 in nucleus and cytoplasm seem to be different [7, 35] and it has been shown that nuclear TRX-1 modulates, in a redoxdependent manner, the DNA binding activity of transcription factors [15, 36] , including nuclear receptors [6, 19] . Taken together, we may speculate that regulation of activity of transcription factors might be one role of TXL-1 within the nucleus and that TXL-1 might be an important factor in protecting nervous system against the effects of hypoglycemia.
TXL-1 expression is clearly modulated by glucose deprivation in HEK-293 cells since TXL-1 protein levels are reduced after 36 h in this condition (see Fig. 5B ).
Unlike TXL-1, TRX-1 levels do not change after 48 h in a glucose-free medium. This result indicates that TXL-1 might be specifically involved in the cellular response to glucose deprivation. It is well accepted that glucose deprivation-induced cytotoxicity is mediated by the generation of ROS, e.g. hydrogen peroxide, that promotes the activation of the c-Jun N-terminal kinase (JNK-1) pathway through the disruption of the interaction between TRX-1 and the apoptosis signaling kinase-1 (ASK-1). The activation of this pathway leads to the progression of the apoptotic process and cell death [29] [30] [31] . However, TXL-1 expression is not affected by hydrogen peroxide exposure, so the effect of glucose deprivation on TXL-1 expression must be mediated through a different pathway where hydrogen peroxide is not involved.
We have also found that overexpression of TXL-1 over a certain threshold can protect HEK-293 cells against glucose deprivation cytotoxicity. Significant differences in cell survival appear after 48 h treatment when comparing clones with highest TXL-1 levels. Before 36 h, cell survival is comparable in all clones, most probably because TXL-1 levels are high enough to maintain the cellular integrity.
However, after 36 h and onwards only the TXL-1-6 clone showing the highest expression level is able to protect cells to some extent from glucose deprivationinduced cytotoxicity. Again, hydrogen peroxide-induced cytotoxicity is not prevented by TXL-1 overexpression supporting our previous idea that TXL-1 must function in a pathway where hydrogen peroxide is not involved.
In summary, we propose TXL-1 to be involved in the cellular response against glucose deprivation. However, more experiments are required to elucidate the specific mechanism and the molecular targets of TXL-1 in this particular process. Homogenous expression can be seen liver (J). Low expression is present in adrenal cortex (co) and medulla (me) (K). In heart very low signal is in heart muscle (L). In skeletal muscle (mu) of tongue low signal is present and the epithelium (arrowheads)
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shows somewhat stronger signal (M). In placenta (pl) strong signal is seen in the fetal part (arrowheads) while maternal part and uterus (triangels) shows low were subjected to western-blot analysis using the anti-TXL-1 and anti-β-actin antibodies. 
